Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

Blood Cancer Journal, Published online: 18 May 2020; doi:10.1038/s41408-020-0326-1Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

http://feeds.nature.com/~r/bcj/rss/current/~3/g6uU6NLWn0o/s41408-020-0326-1

Source: Blood Cancer Journal - May 17, 2020 Category: Hematology Authors: Roberto Mina Angelo Belotti Maria Teresa Petrucci Renato Zambello Andrea Capra Giacomo Di Lullo Sonia Ronconi Norbert Pescosta Mariella Grasso Federico Monaco Claudia Cellini Marco Gobbi Stelvio Ballanti Paolo de Fabritiis Maria Letizia Mosca-Siez Monia M Source Type: research